The U.S. government, which developed and patented the use of Truvada for PrEP, got nothing.
The maker of Truvada enjoyed profit in the billions from sales of the only drug approved for HIV prevention, or pre-exposure prophylaxis (PrEP), in the U.S.
A report in The Washington Post details that the federal government issued $50 million in grants to researchers developing PrEP. Read More
Reading Time: < 1 minute They are the third most commonly used form of contraception in the UK, behind the Pill and the hormonal implant, official data…
Reading Time: < 1 minute An increasing number of people catching the sexually transmitted infection are finding it does not respond to antibiotics. Read More
Reading Time: < 1 minute Sexually transmitted infections (STIs) and reproductive tract infections (RTIs) are major global health issues, impacting quality of life, causing infertility, cancers, and…
Subscribe to our Blog
Let's stay in touch. Subscribe to our blog and get our best content in your inbox.
